# Phase 7 Alignment Review

Status: `complete`

## Parent Alignment

- Phase objective: aligned with Track E Azure and enterprise MCP readiness.
- Direction: on track because the phase provides source-backed architecture guidance without provisioning Azure resources or overclaiming remote MCP implementation.
- Evidence quality before independent review: adequate for docs/design and MCP mode validation; not runtime evidence for remote MCP or Azure deployment.

## Acceptance Criteria Mapping

| Phase 7 acceptance criterion                              | Parent assessment                                                                                                       | Proof status       |
| --------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------- | ------------------ |
| Azure docs useful without provisioning.                   | Expanded Azure guide and added enterprise remote MCP sketch.                                                            | `static_verified`  |
| No resource mutation path without explicit authorization. | MCP remains stdio-only; write tools remain mode-gated; unknown modes now fail before startup.                           | `command_verified` |
| Remote MCP design ready for review.                       | Docs specify auth, audit, Origin validation, allowlists, approval policy, redaction, retention, and read-only defaults. | `static_verified`  |
| Azure deployment not claimed.                             | No Azure provisioning, remote endpoint, or Foundry runtime test occurred.                                               | `not_verified`     |

## Subagent Audit Integration

- Nash audited Azure/Foundry/MCP source claims and recommended claim boundaries, proof statuses, and overclaim avoidance.
- Bohr audited MCP server controls and recommended explicit treatment of remote `workspace-write`, `dangerous-disabled`, and runtime mode validation.

## Independent Review

Independent reviewer Pauli found the phase aligned, on track, strong evidence quality, 95 percent complete, no blockers, no recovery slices, and recommended continuation.
